statnews.com
Three U.S. senators are “alarmed” Novo Nordisk discontinued U.S. sales of a popular insulin and argue the company left patients in the lurch.
9 days ago
statnews.com
“CVS came up with another crafty vehicle to capture money before it goes out the door,” said Chris Brown, who heads McAteer Consulting.
11 days ago
statnews.com
The Justice Department claims Regeneron greatly inflated the costs of its drug to Medicare over many years and enhanced its revenues.
15 days ago
statnews.com
The European Consumer Organization complained the effort does not go far enough to make meaningful changes.
15 days ago
statnews.com
Harrow argues its eye treatment, which has been out of stock for years, is underpriced and requires substantial investment in manufacturing.
16 days ago
statnews.com
There are now 323 ongoing and active drug shortages in the U.S., the highest since the ASHP began tracking data in 2001.
17 days ago
statnews.com
The groups say the government has the right under federal laws to authorize “qualified companies” to make and sell generic versions of Xtandi.
17 days ago
Search by beat, location, outlet & position to find the right journalists for your story.
Sign up for freestatnews.com
A drugmaker in China developed a biosimilar version of Novo Nordisk’s popular diabetes drug Ozempic and applied for approval to sell it there.
22 days ago
statnews.com
Japanese officials searched two Kobayashi Pharmaceutical plants after the drugmaker reported five deaths may be linked to dietary supplements.
25 days ago
statnews.com
Financial ties between drug and device makers and some doctors remain pervasive, despite concerns this may influence medical practice.
28 days ago
statnews.com
“But not all physicians participate in this,” said Andrew Foy, co-author of a new study and an associate professor of medicine at Penn State.
29 days ago
